Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
766.68 | -48.51% | -27.38% | 690,322.8 | 0.71% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
148.58 | 0% | 0% | 357,584.39 | 3.32% | 2.71% |
|
NYSE:MRK
Merck
|
127.57 | -7.46% | 6.1% | 323,110.1 | 2.42% | -19.03% |
|
NYSE:PFE
Pfizer
|
28.16 | 10.25% | 40.97% | 159,457.16 | 6.04% | -9.31% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
958.64 | -27.86% | -21.71% | 105,628.23 | 0% | 13.9% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
402.50 | 8.28% | 16.85% | 104,029.89 | 0% | 30.14% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.90 | 62.22% | 72.59% | 88,989.69 | 5.46% | 13.54% |
|
NYSE:ZTS
Zoetis
|
165.95 | 33.32% | 49.83% | 75,722.18 | 1.03% | 11.19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
151.22 | 0% | 0% | 19,128.09 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
36.51 | 76.47% | 103.09% | 18,604.77 | 3.14% | -3.14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.82 | 1.95% | 12.16% | 13,740.18 | 4.07% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
260.51 | -9.47% | 0.04% | 11,641.77 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
56.37 | -57.79% | -7.9% | 10,225.04 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
65.05 | 0% | 0% | 6,838.6 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
42.28 | -,153.3% | -,146.3% | 6,121.15 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
153.32 | -0.56% | 9% | 4,561.9 | 0.53% | 5.85% |
|
NYSE:PRGO
Perrigo Co PLC
|
33.43 | 39.65% | 63.25% | 4,425.95 | 3.37% | -15.93% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
235.57 | 0% | 0% | 5,014.01 | 0% | 0% |
|
NasdaqGS:NEOG
Neogen
|
12.14 | 135.45% | 235.73% | 2,670.77 | 0% | -1.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
23.97 | -34.78% | -10.92% | 2,552.83 | 0% | 2.03% |
